STAT+: Medicare announces drug prices for historic first round of negotiations
STAT
AUGUST 15, 2024
WASHINGTON — The day drug makers dreaded has finally arrived. Medicare officials on Thursday unveiled the results of the program’s first 10 drug price negotiations, despite the industry’s two-decade, multimillion-dollar lobbying campaign and barrage of lawsuits to stop them. The drugs that received negotiated prices include Bristol Myers Squibb’s blood thinner Eliquis, Boehringer Ingelheim’s diabetes drug Jardiance, Johnson & Johnson’s bl
Let's personalize your content